Clinical Trials Browser

Phase 1 × Infectious Mononucleosis × 90 days × Clear all

NCT06908096 2026-03-06

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

Phase 1 Recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections